Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori surface proteins and cell envelope components represent a diverse group of molecules essential for the bacterium's survival, colonization, and pathogenesis within the human gastric mucosa (StatPearls: Helicobacter Pylori). This category includes outer membrane proteins (OMPs) such as BabA and SabA, which mediate adhesion to gastric epithelial cells, as well as structural components like peptidoglycan and lipopolysaccharide (LPS) (PubMed: PMID 12472991). These components are critical for maintaining structural integrity and facilitating the delivery of virulence factors like VacA and CagA into host cells (NIH: Helicobacter pylori and Cancer). From a therapeutic perspective, these surface structures are primary targets for antibiotics; for instance, beta-lactams like amoxicillin interfere with peptidoglycan cross-linking, leading to bacterial lysis (StatPearls: Helicobacter Pylori). Additionally, surface proteins like urease, which is often surface-associated, are the focus of vaccine development efforts aimed at inducing neutralizing antibodies (UniProt: P14916). Understanding the composition and variability of the H. pylori cell envelope is vital for overcoming challenges such as antibiotic resistance and the bacteria's sophisticated immune evasion mechanisms, including molecular mimicry (PubMed: PMID 10843059). However, because this target represents a broad collection of distinct molecular entities rather than a single protein, it is often categorized as a target class in drug discovery contexts.
Inhibition of bacterial cell wall peptidoglycan synthesis, disruption of cytoplasmic membrane integrity, and interference with surface-associated enzyme activity (StatPearls: Helicobacter Pylori).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori surface proteins and cell envelope components (H. pylori surface/envelope).